login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VASCULAR BIOGENICS LTD (VBLT) Stock News
USA
- NASDAQ:VBLT -
IL0011327454
-
Common Stock
0.156
USD
-0.02 (-8.77%)
Last: 10/16/2023, 8:02:23 PM
0.168
USD
+0.01 (+7.69%)
After Hours:
10/16/2023, 8:02:23 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VBLT Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: VBL Therapeutics
VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting
2 years ago - By: Benzinga
- Mentions:
SONX
RVLP
MSS
PEV
...
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
2 years ago - By: Benzinga
- Mentions:
TMPO
MKUL
PRZO
XRTX
...
Why Avidity Biosciences Shares Are Trading Higher By Around 9%: 20 Stocks Moving Premarket
2 years ago - By: VBL Therapeutics
VBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meeting
2 years ago - By: InvestorPlace
- Mentions:
SGBX
NIR
SCLX
MURF
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
2 years ago - By: VBL Therapeutics
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
2 years ago - By: Kahn Swick & Foti, LLC
VASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLT
2 years ago - By: VBL Therapeutics
VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
2 years ago - By: VBL Therapeutics
VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
3 years ago - By: VBL Therapeutics
VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
3 years ago - By: Seeking Alpha
Vascular Biogenics stock dips amid sale of manufacturing facility to Aleph Farms
3 years ago - By: Kahn Swick & Foti, LLC
VASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLT
3 years ago - By: InvestorPlace
- Mentions:
CING
BAER
AVGR
LUNR
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
3 years ago - By: InvestorPlace
- Mentions:
NVDA
AMD
INTC
TSM
...
Why Are Chip Stocks Up Today?
3 years ago - By: InvestorPlace
- Mentions:
WBA
TDOC
GE
Why Is Vascular Biogenics (VBLT) Stock Up 52%?
3 years ago - By: Halper Sadeh LLC
VBLT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Vascular Biogenics Ltd. Is Fair to Shareholders
3 years ago - By: Seeking Alpha
VBLT stock rises on all-stock merger deal with Notable Labs (NASDAQ:VBLT)
3 years ago - By: VBL Therapeutics
VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement
3 years ago - By: VBL Therapeutics
VBL Therapeutics Announces Agreement to Sell Manufacturing Facility and Certain Related Assets for $7.1 Million in Cash
3 years ago - By: VBL Therapeutics
VBL Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Please enable JavaScript to continue using this application.